151 related articles for article (PubMed ID: 24733138)
1. Predictors of naloxone use for respiratory depression and oversedation in hospitalized adults.
Pawasauskas J; Stevens B; Youssef R; Kelley M
Am J Health Syst Pharm; 2014 May; 71(9):746-50. PubMed ID: 24733138
[TBL] [Abstract][Full Text] [Related]
2. Predictors of Delayed Postoperative Respiratory Depression Assessed from Naloxone Administration.
Weingarten TN; Herasevich V; McGlinch MC; Beatty NC; Christensen ED; Hannifan SK; Koenig AE; Klanke J; Zhu X; Gali B; Schroeder DR; Sprung J
Anesth Analg; 2015 Aug; 121(2):422-9. PubMed ID: 25993390
[TBL] [Abstract][Full Text] [Related]
3. Patterns of naloxone use in hospitalized patients.
Yung L; Lee KC; Hsu C; Furnish T; Atayee RS
Postgrad Med; 2017 Jan; 129(1):40-45. PubMed ID: 27858510
[TBL] [Abstract][Full Text] [Related]
4. Incidence and Demographics of Post-Operative Naloxone Administration: A 13-Year Experience at a Major Tertiary Teaching Institution.
Khelemsky Y; Kothari R; Campbell N; Farnad S
Pain Physician; 2015; 18(5):E827-9. PubMed ID: 26431136
[TBL] [Abstract][Full Text] [Related]
5. Implementation of solutions to reduce opioid-induced oversedation and respiratory depression.
Meisenberg B; Ness J; Rao S; Rhule J; Ley C
Am J Health Syst Pharm; 2017 Feb; 74(3):162-169. PubMed ID: 27993764
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the appropriateness of naloxone administration to patients receiving long-term opioid therapy.
Facey C; Brooks D; Boland JW
Hosp Pract (1995); 2016; 44(2):86-91. PubMed ID: 26837434
[TBL] [Abstract][Full Text] [Related]
7. Predictors of oversedation in hospitalized patients.
Brant JM; Stringer L; Jurkovich LR; Coombs NC; Mullette EJ; Buffington C; Herbert S; Karera D
Am J Health Syst Pharm; 2018 Sep; 75(18):1378-1385. PubMed ID: 30190295
[TBL] [Abstract][Full Text] [Related]
8. Findings of a Naloxone Database and its Utilization to Improve Safety and Education in a Tertiary Care Medical Center.
Rosenfeld DM; Betcher JA; Shah RA; Chang YH; Cheng MR; Cubillo EI; Griffin JM; Trentman TL
Pain Pract; 2016 Mar; 16(3):327-33. PubMed ID: 25564757
[TBL] [Abstract][Full Text] [Related]
9. Reversal of Opioid-Induced Ventilatory Depression Using Low-Dose Naloxone (0.04 mg): a Case Series.
Kim HK; Nelson LS
J Med Toxicol; 2016 Mar; 12(1):107-10. PubMed ID: 26289651
[TBL] [Abstract][Full Text] [Related]
10. Risk predictors of opioid-induced critical respiratory events in children: naloxone use as a quality measure of opioid safety.
Chidambaran V; Olbrecht V; Hossain M; Sadhasivam S; Rose J; Meyer MJ
Pain Med; 2014 Dec; 15(12):2139-49. PubMed ID: 25319840
[TBL] [Abstract][Full Text] [Related]
11. Predicting opioid-induced oversedation in hospitalised patients: a multicentre observational study.
Garrett J; Vanston A; Ogola G; da Graca B; Cassity C; Kouznetsova MA; Hall LR; Qiu T
BMJ Open; 2021 Nov; 11(11):e051663. PubMed ID: 34819283
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for opioid toxicity requiring naloxone rescue in adults: a case-control study.
Beyene K; Shen W; Mitchell T; Gilson S; Kang S; Lai D; Misquitta L; Slaimankhel A; Chan AHY
Int J Clin Pharm; 2022 Dec; 44(6):1296-1303. PubMed ID: 35896908
[TBL] [Abstract][Full Text] [Related]
13. Predictors and outcomes following naloxone administration during Phase I anesthesia recovery.
Weingarten TN; Chong EY; Schroeder DR; Sprung J
J Anesth; 2016 Feb; 30(1):116-22. PubMed ID: 26449674
[TBL] [Abstract][Full Text] [Related]
14. Opioid-induced respiratory effects: new data on buprenorphine.
Dahan A
Palliat Med; 2006; 20 Suppl 1():s3-8. PubMed ID: 16764215
[TBL] [Abstract][Full Text] [Related]
15. Importance of the correct diagnosis of opioid-induced respiratory depression in adult cancer patients and titration of naloxone.
Boland J; Boland E; Brooks D
Clin Med (Lond); 2013 Apr; 13(2):149-51. PubMed ID: 23681862
[TBL] [Abstract][Full Text] [Related]
16. Pattern of perioperative gabapentinoid use and risk for postoperative naloxone administration.
Deljou A; Hedrick SJ; Portner ER; Schroeder DR; Hooten WM; Sprung J; Weingarten TN
Br J Anaesth; 2018 Apr; 120(4):798-806. PubMed ID: 29576120
[TBL] [Abstract][Full Text] [Related]
17. Naloxone pro-drug rescues morphine induced respiratory depression in Sprague-Dawley rats.
Wallisch M; El Rody NM; Huang B; Koop DR; Baker JR; Olsen GD
Respir Physiol Neurobiol; 2012 Jan; 180(1):52-60. PubMed ID: 22027217
[TBL] [Abstract][Full Text] [Related]
18. Postoperative opioid-induced respiratory depression or oversedation requiring naloxone treatment in a community hospital: a case series.
Newgaard OR; Weingarten TN; Sprung J; Suginaka AT; Gurrieri C
Proc (Bayl Univ Med Cent); 2024; 37(1):55-60. PubMed ID: 38174010
[TBL] [Abstract][Full Text] [Related]
19. Noradrenergic Mechanisms in Fentanyl-Mediated Rapid Death Explain Failure of Naloxone in the Opioid Crisis.
Torralva R; Janowsky A
J Pharmacol Exp Ther; 2019 Nov; 371(2):453-475. PubMed ID: 31492824
[TBL] [Abstract][Full Text] [Related]
20. Incidence and Outcomes of Life-Threatening Events During Hospitalization: A Retrospective Study of Patients Treated with Naloxone.
Valencia Morales DJ; Laporta ML; Meehan AM; Schroeder DR; Sprung J; Weingarten TN
Pain Med; 2022 May; 23(5):878-886. PubMed ID: 34668555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
